Voloridge Investment Management LLC Buys Shares of 30,156 Pediatrix Medical Group, Inc. (NYSE:MD)

Voloridge Investment Management LLC purchased a new stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 30,156 shares of the company's stock, valued at approximately $396,000.

Several other hedge funds also recently modified their holdings of the company. Nomura Asset Management Co. Ltd. grew its position in Pediatrix Medical Group by 95.3% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock worth $33,000 after buying an additional 1,220 shares during the last quarter. Parkside Financial Bank & Trust boosted its stake in shares of Pediatrix Medical Group by 36.1% during the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock worth $51,000 after acquiring an additional 1,040 shares in the last quarter. AlphaQuest LLC boosted its stake in shares of Pediatrix Medical Group by 65.9% during the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock worth $66,000 after acquiring an additional 2,012 shares in the last quarter. Smartleaf Asset Management LLC grew its holdings in shares of Pediatrix Medical Group by 750.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock worth $91,000 after acquiring an additional 6,090 shares during the last quarter. Finally, Tower Research Capital LLC TRC raised its position in shares of Pediatrix Medical Group by 218.0% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock worth $98,000 after purchasing an additional 5,104 shares during the period. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Pediatrix Medical Group Stock Down 0.6%

NYSE MD traded down $0.08 during trading on Friday, reaching $14.15. 968,608 shares of the company's stock were exchanged, compared to its average volume of 855,808. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $17.67. The company's fifty day simple moving average is $13.72 and its 200-day simple moving average is $14.04. The firm has a market capitalization of $1.22 billion, a PE ratio of -11.79, a P/E/G ratio of 1.74 and a beta of 1.26.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.25 by $0.08. The business had revenue of $458.36 million during the quarter, compared to analyst estimates of $451.44 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The firm's revenue was down 7.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.20 earnings per share. Sell-side analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the company. Macquarie increased their price target on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a research report on Thursday, May 8th. UBS Group decreased their target price on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating for the company in a report on Monday, May 12th. Finally, Truist Financial dropped their target price on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a research report on Friday, April 11th. Four analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $16.67.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.